# Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant), Wenzhou, China – FDA Inspections

Source: https://www.keypedia.com/companies/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/13be9174-238f-43cf-bdf4-0c57cc0b0bc2

> Inspection records and compliance data for Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) in Wenzhou. 5 FDA inspections on record, 1 Form 483, last inspected March 14, 2025.

---

## Details

- Name: Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)
- FEI Number: 3010728912
- Business Operations: API MANUFACTURE
- Address Line 1: Economic & Technological Development Zon, NO. 555 the 8th Binhai Rd., Binhai Indus
- City: Wenzhou
- Country Name: China
- Address: Economic & Technological Development Zon, NO. 555 the 8th Binhai Rd., Binhai Indus, Wenzhou, China
- Country: China

## Related Documents

- [FDA Inspection 1261674 - Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) - 2025-03-14](https://www.keypedia.com/records/fda_inspections/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/c4db414c-686b-4498-a4b8-2022ce9c30ef) — source: FDA, date: March 14, 2025
- FDA Inspection 1261674 - Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) - 2025-03-14 — classification: No Action Indicated (NAI), source: FDA, date: March 14, 2025
- [483 - Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) - 2019-03-22](https://www.keypedia.com/records/483/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/39f6750c-499f-4041-a4d2-0acaa910a734) — source: FDA, date: March 22, 2019
- [FDA Inspection 1084107 - Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) - 2019-03-22](https://www.keypedia.com/records/fda_inspections/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/98b9736f-c6d4-4c5c-9113-69846725a990) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 22, 2019
- FDA Inspection 981968 - Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) - 2016-07-22 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 22, 2016
- FDA Inspection 866095 - Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) - 2013-12-20 — classification: No Action Indicated (NAI), source: FDA, date: December 20, 2013
- FDA Inspection 582495 - Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) - 2009-04-23 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 23, 2009

## Related Companies

- [Wuhan Biocause Pharmaceutical Development Co., Ltd.](https://www.keypedia.com/companies/wuhan-biocause-pharmaceutical-development-co-ltd/79c352a3-22a2-471e-abbe-1802683656eb)
- [Jiangxi Synergy Pharmaceutical, Co., Ltd.](https://www.keypedia.com/companies/jiangxi-synergy-pharmaceutical-co-ltd/9602f29a-9a10-4201-966c-b89b6a2d3ae5)
- [Aarti Pharmalabs Limited](https://www.keypedia.com/companies/aarti-pharmalabs-limited/94a0adf3-5840-4cc1-9582-8eafd52d498e)
- [Arch Pharmalabs Ltd.](https://www.keypedia.com/companies/arch-pharmalabs-ltd/2766781c-7a1a-4718-bb0e-04fa9616a574)
- [Huber Soda, LLC](https://www.keypedia.com/companies/huber-soda-llc/89d2a595-ba2c-46a2-987c-65bb21b1b75b)
- [Zach System S.A.](https://www.keypedia.com/companies/zach-system-sa/c663917a-2b9d-4375-bc79-2cdd0e280002)
- [Cadila Pharmaceuticals Limited](https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/042118cf-4e9b-432b-b155-94c2b5e3e025)
- [Natco Pharma Ltd. - Chemical Division](https://www.keypedia.com/companies/natco-pharma-ltd-chemical-division/3d56c2ac-4a7d-4f9f-8987-966d0ff5e5f1)
- [Somerville Acquisitions, Inc.](https://www.keypedia.com/companies/somerville-acquisitions-inc/195f0557-96af-4562-98e7-9e03150b33cb)
- [Harman Finochem Limited](https://www.keypedia.com/companies/harman-finochem-limited/7622941a-bad2-45c3-bd91-07d2bb63f905)

## Related Officers

- [Senior Director Technical](https://www.keypedia.com/people/christopher-t-middendorf/0fea23f5-ffe6-49a0-ac33-780317707c71)
